JPWO2020231776A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020231776A5 JPWO2020231776A5 JP2021567062A JP2021567062A JPWO2020231776A5 JP WO2020231776 A5 JPWO2020231776 A5 JP WO2020231776A5 JP 2021567062 A JP2021567062 A JP 2021567062A JP 2021567062 A JP2021567062 A JP 2021567062A JP WO2020231776 A5 JPWO2020231776 A5 JP WO2020231776A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- formula
- unsubstituted
- compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962846457P | 2019-05-10 | 2019-05-10 | |
US62/846,457 | 2019-05-10 | ||
US202062962048P | 2020-01-16 | 2020-01-16 | |
US62/962,048 | 2020-01-16 | ||
PCT/US2020/032016 WO2020231776A1 (en) | 2019-05-10 | 2020-05-08 | Small molecule modulators of gut bacterial bile acid metabolism |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022533069A JP2022533069A (ja) | 2022-07-21 |
JPWO2020231776A5 true JPWO2020231776A5 (zh) | 2023-05-16 |
Family
ID=73289482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021567062A Pending JP2022533069A (ja) | 2019-05-10 | 2020-05-08 | 腸内細菌胆汁酸代謝の小分子モジュレーター |
Country Status (9)
Country | Link |
---|---|
US (1) | US20220204548A1 (zh) |
EP (1) | EP3965748A4 (zh) |
JP (1) | JP2022533069A (zh) |
KR (1) | KR20220007112A (zh) |
CN (1) | CN114641280A (zh) |
AU (1) | AU2020274319A1 (zh) |
BR (1) | BR112021022431A2 (zh) |
CA (1) | CA3137308A1 (zh) |
WO (1) | WO2020231776A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021174024A1 (en) | 2020-02-28 | 2021-09-02 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
IT202200008861A1 (it) * | 2022-05-03 | 2023-11-03 | Chemelectiva S R L | Processo per la preparazione di derivati dell’acido colico. |
CN115337312A (zh) * | 2022-08-19 | 2022-11-15 | 金熊药业(珠海横琴)有限公司 | 胆酸复合物及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140206657A1 (en) * | 2013-01-18 | 2014-07-24 | City Of Hope | Bile acid analog tgr5 agonists |
CN107531743B (zh) * | 2015-04-29 | 2020-05-05 | 正大天晴药业集团股份有限公司 | 鹅去氧胆酸衍生物 |
TWI618714B (zh) * | 2015-08-27 | 2018-03-21 | 中央研究院 | 涎酸轉移酶抑制劑及其用途 |
WO2017142895A1 (en) * | 2016-02-15 | 2017-08-24 | Regents Of The University Of Minnesota | Compositions and methods for treating clostridium associated diseases |
US20170233431A1 (en) * | 2016-02-17 | 2017-08-17 | City Of Hope | Bile acid derivatives and methods for synthesis and use |
US11155573B2 (en) * | 2017-10-13 | 2021-10-26 | Battelle Memorial Institute | Bile salt hydrolase probe and method of making and using the same |
-
2020
- 2020-05-08 JP JP2021567062A patent/JP2022533069A/ja active Pending
- 2020-05-08 AU AU2020274319A patent/AU2020274319A1/en active Pending
- 2020-05-08 US US17/610,037 patent/US20220204548A1/en active Pending
- 2020-05-08 KR KR1020217040058A patent/KR20220007112A/ko unknown
- 2020-05-08 CN CN202080050183.1A patent/CN114641280A/zh active Pending
- 2020-05-08 EP EP20805532.7A patent/EP3965748A4/en active Pending
- 2020-05-08 WO PCT/US2020/032016 patent/WO2020231776A1/en unknown
- 2020-05-08 CA CA3137308A patent/CA3137308A1/en active Pending
- 2020-05-08 BR BR112021022431A patent/BR112021022431A2/pt unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4264137B2 (ja) | 抗血栓性有機硝酸塩 | |
JP2004535452A (ja) | 肥満症の治療のためのアリールボロン酸 | |
JP2008511601A5 (zh) | ||
JP5468007B2 (ja) | 新規なプロスタグランジンi2誘導体 | |
JP2005506348A5 (zh) | ||
IL149601A (en) | Coubertstatin A – 4 Phosphatogenic Amino- and Dio-Organic Amino Salts, Mono- and Dio-Amino Acid Salts, and Aster-Mono- and Dio-Amino Acid Salts | |
JP2009524691A5 (zh) | ||
WO2006043655A1 (ja) | 吸入用医薬組成物 | |
US20070060544A1 (en) | 4-Nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivatives and their pharmaceutical use | |
KR20110013411A (ko) | (f-19)-표지된 l-글루탐산 및 l-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법 | |
EP3077009A1 (en) | Molecular imaging probes | |
JPH08508720A (ja) | ピロールーアミジン化合物およびその薬剤的に受容できる塩、その製造法ならびにこれを含む医薬組成物 | |
JPWO2020123827A5 (zh) | ||
JP2007505044A5 (zh) | ||
JPWO2019148044A5 (zh) | ||
JPH11501288A (ja) | 金属タンパク質分解酵素阻害剤 | |
JP2011527330A (ja) | スニチニブリンゴ酸塩の結晶形の調製方法 | |
CA2526991A1 (en) | Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor | |
JP2006515866A5 (zh) | ||
FR2840301A1 (fr) | Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique | |
JPWO2020231776A5 (zh) | ||
TW201139421A (en) | Novel ep4 agonist | |
JP2007519685A5 (zh) | ||
GB2131795A (en) | Benzofurans and benzothiophenes | |
JPWO2021049504A5 (zh) |